Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T10586
(Former ID: TTDI02118)
|
|||||
Target Name |
Lysozyme (LYZ)
|
|||||
Synonyms |
Lysozyme C; LYZ; 1,4betaNacetylmuramidase C
Click to Show/Hide
|
|||||
Gene Name |
LYZ
|
|||||
Target Type |
Literature-reported target
|
[1] | ||||
Function |
Lysozymes have primarily a bacteriolytic function; those intissues and body fluids are associated with the monocyte- macrophage system and enhance the activity of immunoagents.
Click to Show/Hide
|
|||||
BioChemical Class |
Glycosylase
|
|||||
UniProt ID | ||||||
EC Number |
EC 3.2.1.17
|
|||||
Sequence |
MKALIVLGLVLLSVTVQGKVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRA
TNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRD PQGIRAWVAWRNRCQNRDVRQYVQGCGV Click to Show/Hide
|
|||||
3D Structure | Click to Show 3D Structure of This Target | PDB | ||||
ADReCS ID | BADD_A02521 ; BADD_A03025 ; BADD_A03769 | |||||
HIT2.0 ID | T57CRF |
Cell-based Target Expression Variations | Top | |||||
---|---|---|---|---|---|---|
Cell-based Target Expression Variations |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
Ligand Name: Acetylcysteine | Ligand Info | |||||
Structure Description | MUTANT HUMAN LYSOZYME C77A | PDB:207L | ||||
Method | X-ray diffraction | Resolution | 1.80 Å | Mutation | Yes | [2] |
PDB Sequence |
KVFERCELAR
10 TLKRLGMDGY20 RGISLANWMC30 LAKWESGYNT40 RATNYNAGDR50 STDYGIFQIN 60 SRYWCNDGKT70 PGAVNAAHLS80 CSALLQDNIA90 DAVACAKRVV100 RDPQGIRAWV 110 AWRNRCQNRD120 VRQYVQGCGV130
|
|||||
|
||||||
Ligand Name: Glutathione | Ligand Info | |||||
Structure Description | CRYSTAL STRUCTURE OF A GLUTATHIONYLATED HUMAN LYSOZYME: A FOLDING INTERMEDIATE MIMIC IN THE FORMATION OF A DISULFIDE BOND | PDB:1HNL | ||||
Method | X-ray diffraction | Resolution | 1.80 Å | Mutation | No | [3] |
PDB Sequence |
KVFERCELAR
10 TLKRLGMDGY20 RGISLANWMC30 LAKWESGYNT40 RATNYNAGDR50 STDYGIFQIN 60 SRYWCNDGKT70 PGAVNAAHLS80 CSALLQDNIA90 DAVACAKRVV100 RDPQGIRAWV 110 AWRNRCQNRD120 VRQYVQGCGV130
|
|||||
|
||||||
Click to View More Binding Site Information of This Target with Different Ligands |
Different Human System Profiles of Target | Top |
---|---|
Human Similarity Proteins
of target is determined by comparing the sequence similarity of all human proteins with the target based on BLAST. The similarity proteins for a target are defined as the proteins with E-value < 0.005 and outside the protein families of the target.
A target that has fewer human similarity proteins outside its family is commonly regarded to possess a greater capacity to avoid undesired interactions and thus increase the possibility of finding successful drugs
(Brief Bioinform, 21: 649-662, 2020).
Human Tissue Distribution
of target is determined from a proteomics study that quantified more than 12,000 genes across 32 normal human tissues. Tissue Specificity (TS) score was used to define the enrichment of target across tissues.
The distribution of targets among different tissues or organs need to be taken into consideration when assessing the target druggability, as it is generally accepted that the wider the target distribution, the greater the concern over potential adverse effects
(Nat Rev Drug Discov, 20: 64-81, 2021).
Human Pathway Affiliation
of target is determined by the life-essential pathways provided on KEGG database. The target-affiliated pathways were defined based on the following two criteria (a) the pathways of the studied target should be life-essential for both healthy individuals and patients, and (b) the studied target should occupy an upstream position in the pathways and therefore had the ability to regulate biological function.
Targets involved in a fewer pathways have greater likelihood to be successfully developed, while those associated with more human pathways increase the chance of undesirable interferences with other human processes
(Pharmacol Rev, 58: 259-279, 2006).
Human Similarity Proteins
Human Tissue Distribution
Human Pathway Affiliation
|
There is no similarity protein (E value < 0.005) for this target
|
Note:
If a protein has TS (tissue specficity) scores at least in one tissue >= 2.5, this protein is called tissue-enriched (including tissue-enriched-but-not-specific and tissue-specific). In the plots, the vertical lines are at thresholds 2.5 and 4.
|
KEGG Pathway | Pathway ID | Affiliated Target | Pathway Map |
---|---|---|---|
Salivary secretion | hsa04970 | Affiliated Target |
|
Class: Organismal Systems => Digestive system | Pathway Hierarchy |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | Protective properties of lysozyme on -amyloid pathology: implications for Alzheimer disease. Neurobiol Dis. 2015 Nov;83:122-33. | |||||
REF 2 | A role of PDI in the reductive cleavage of mixed disulfides. J Biochem. 1996 Sep;120(3):525-30. | |||||
REF 3 | Structure of a glutathionylated human lysozyme: a folding intermediate mimic in the formation of a disulfide bond. Acta Crystallogr D Biol Crystallogr. 1995 Sep 1;51(Pt 5):619-25. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.